Eiger BioPharmaceuticals Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Eiger BioPharmaceuticals is a biotechnology company focused on developing therapies for rare metabolic diseases and operates at the commercial stage. Its lead program, avexitide, is a first-in-class GLP-1 antagonist intended to treat post-bariatric hypoglycemia and congenital hyperinsulinism. Avexitide has received Breakthrough Therapy designation from the FDA. The company is based in Palo Alto, California, and works within the biotechnology research sector. Its target market includes patients with PBH and HI and clinicians seeking new treatment options for these conditions. The organization aims to advance therapies for rare metabolic diseases by translating clinical insights into available therapeutic options.